{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T21:05:32Z","timestamp":1790975132409,"version":"4.1.0"},"reference-count":111,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T00:00:00Z","timestamp":1599177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Vaccines are considered one of the most important bioproducts in medicine. Since the development of the smallpox vaccine in 1796, several types of vaccines for many diseases have been created. However, some vaccines have shown limitations as high cost and low immune responses. In that regard, bacteriophages have been proposed as an attractive alternative for the development of more cost-effective vaccines. Phage-displayed vaccines consists in the expression of antigens on the phage surface. This approach takes advantage of inherent properties of these particles such as their adjuvant capacity, economic production and high stability, among others. To date, three types of phage-based vaccines have been developed: phage-displayed, phage DNA and hybrid phage-DNA vaccines. Typically, phage display technology has been used for the identification of new and protective epitopes, mimotopes and antigens. In this context, phage particles represent a versatile, effective and promising alternative for the development of more effective vaccine delivery systems which should be highly exploited in the future. This review describes current advances in the development of bacteriophage-based vaccines, with special attention to vaccine delivery strategies. Moreover, the immunological aspects of phage-based vaccines, as well as the applications of phage display for vaccine development, are explored. Finally, important challenges and the future of phage-bases vaccines are discussed.<\/jats:p>","DOI":"10.3390\/vaccines8030504","type":"journal-article","created":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T11:24:24Z","timestamp":1599218664000},"page":"504","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":91,"title":["Bacteriophage-Based Vaccines: A Potent Approach for Antigen Delivery"],"prefix":"10.3390","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3605-7522","authenticated-orcid":false,"given":"Alejandro","family":"Gonz\u00e1lez-Mora","sequence":"first","affiliation":[{"name":"Tecnologico de Monterrey, School of Engineering and Sciences, Ave. Eugenio Garza Sada 2501, Monterrey, N.L. 64849, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5413-3245","authenticated-orcid":false,"given":"Jes\u00fas","family":"Hern\u00e1ndez-P\u00e9rez","sequence":"additional","affiliation":[{"name":"Tecnologico de Monterrey, School of Engineering and Sciences, Ave. Eugenio Garza Sada 2501, Monterrey, N.L. 64849, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4855-2720","authenticated-orcid":false,"given":"Hafiz M. N.","family":"Iqbal","sequence":"additional","affiliation":[{"name":"Tecnologico de Monterrey, School of Engineering and Sciences, Ave. Eugenio Garza Sada 2501, Monterrey, N.L. 64849, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Rito-Palomares","sequence":"additional","affiliation":[{"name":"Tecnologico de Monterrey, School of Medicine and Health Sciences, Ave. Morones Prieto 3000 Pte, Monterrey, N.L. 64710, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Benavides","sequence":"additional","affiliation":[{"name":"Tecnologico de Monterrey, School of Engineering and Sciences, Ave. Eugenio Garza Sada 2501, Monterrey, N.L. 64849, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,9,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"20130433","DOI":"10.1098\/rstb.2013.0433","article-title":"The contribution of vaccination to global health: Past, present and future","volume":"369","author":"Greenwood","year":"2014","journal-title":"Philos. Trans. R. Soc. B Biol. Sci."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1016\/j.vaccine.2008.03.042","article-title":"Inexpensive anti-cysticercosis vaccine: S3Pvac expressed in heat inactivated M13 filamentous phage proves effective against naturally acquired Taenia solium porcine cysticercosis","volume":"26","author":"Morales","year":"2008","journal-title":"Vaccine"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1574-695X.2010.00763.x","article-title":"Comparison of a bacteriophage-delivered DNA vaccine and a commercially available recombinant protein vaccine against hepatitis B","volume":"61","author":"Clark","year":"2011","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.biori.2017.10.001","article-title":"The development of veterinary vaccines: A review of traditional methods and modern biotechnology approaches","volume":"1","author":"Jorge","year":"2017","journal-title":"Biotechnol. Res. Innov."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1080\/14760584.2017.1306441","article-title":"Influence of protein fold stability on immunogenicity and its implications for vaccine design","volume":"16","author":"Scheiblhofer","year":"2017","journal-title":"Expert Rev. Vaccines"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"a012518","DOI":"10.1101\/cshperspect.a012518","article-title":"Therapeutic and Prophylactic Applications of Bacteriophage Components in Modern Medicine","volume":"4","author":"Adhya","year":"2014","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s13071-015-0747-z","article-title":"Use of Phage Display technology in development of canine visceral leishmaniasis vaccine using synthetic peptide trapped in sphingomyelin\/cholesterol liposomes","volume":"8","author":"Bueno","year":"2015","journal-title":"Parasites Vectors"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Hobernik, D., and Bros, M. (2018). DNA Vaccines\u2014How Far From Clinical Use?. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19113605"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3390\/vaccines2030515","article-title":"Peptide Vaccine: Progress and Challenges","volume":"2","author":"Li","year":"2014","journal-title":"Vaccines"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1007\/s00253-014-5521-1","article-title":"Bacteriophage lambda display systems: Developments and applications","volume":"98","author":"Nicastro","year":"2014","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jviromet.2012.03.032","article-title":"Infective and inactivated filamentous phage as carriers for immunogenic peptides","volume":"183","author":"Samoylova","year":"2012","journal-title":"J. Virol. Methods"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4318","DOI":"10.1016\/S0021-9258(18)68927-6","article-title":"Immunogenicity and epitope mapping of foreign sequences via genetically engineered filamentous phage","volume":"263","author":"Lal","year":"1988","journal-title":"J. Biol. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1002\/jctb.5359","article-title":"Recovery and primary purification of bacteriophage M13 using aqueous two-phase systems","volume":"92","author":"Benavides","year":"2017","journal-title":"J. Chem. Technol. Biotechnol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1743-422X-9-9","article-title":"Bacteriophages and their implications on future biotechnology: A review","volume":"9","author":"Haq","year":"2012","journal-title":"Virol. J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"10416","DOI":"10.1073\/pnas.0403795101","article-title":"Treating cocaine addiction with viruses","volume":"101","author":"Carrera","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/S0264-410X(02)00609-6","article-title":"Reduction of \u03b2-amyloid plaques in brain of transgenic mouse model of Alzheimer\u2019s disease by EFRH-phage immunization","volume":"21","author":"Frenkel","year":"2003","journal-title":"Vaccine"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3109\/08923973.2015.1027917","article-title":"Cancer immunotherapy by a recombinant phage vaccine displaying EGFR mimotope: Anin vivostudy","volume":"37","author":"Ghaemmaghami","year":"2015","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Gu, Y., Wei, J., Yang, J., Huang, J., Yang, X., and Zhu, X. (2013). Protective Immunity against Trichinella spiralis Infection Induced by a Multi-Epitope Vaccine in a Murine Model. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0077238"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.vetimm.2003.12.009","article-title":"Recombinant bacteriophage-based multiepitope vaccine against Taenia solium pig cysticercosis","volume":"99","author":"Manoutcharian","year":"2004","journal-title":"Veter. Immunol. Immunopathol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.apjtb.2017.06.001","article-title":"An overview on application of phage display technique in immunological studies","volume":"7","author":"Rami","year":"2017","journal-title":"Asian Pac. J. Trop. Biomed."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/s41467-017-01055-9","article-title":"Phage-assisted continuous evolution of proteases with altered substrate specificity","volume":"8","author":"Packer","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.toxicon.2010.03.005","article-title":"Rapid isolation of single-chain antibodies by phage display technology directed against one of the most potent marine toxins: Palytoxin","volume":"55","author":"Garet","year":"2010","journal-title":"Toxicon"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.actatropica.2016.03.018","article-title":"Targeting Leishmania major parasite with peptides derived from a combinatorial phage display library","volume":"159","author":"Houimel","year":"2016","journal-title":"Acta Trop."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Tang, C.-T., Li, P.-C., Liu, I.-J., Liao, M.-Y., Chiu, C.-Y., Chao, D.-Y., and Wu, H.-C. (2015). An Epitope-Substituted DNA Vaccine Improves Safety and Immunogenicity against Dengue Virus Type 2. PLoS Negl. Trop. Dis., 9.","DOI":"10.1371\/journal.pntd.0003903"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.4161\/hv.21703","article-title":"Phage display\u2014A powerful technique for immunotherapy","volume":"8","author":"Bazan","year":"2012","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.chroma.2017.12.005","article-title":"M13 bacteriophage purification using poly(ionic liquids) as alternative separation matrices","volume":"1532","author":"Jacinto","year":"2018","journal-title":"J. Chromatogr. A"},{"key":"ref_27","first-page":"51","article-title":"Filamentous bacteriophage: Biology, phage display and nanotechnology applications","volume":"13","author":"Rakonjac","year":"2011","journal-title":"Curr. Issues Mol. Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.biotechadv.2010.07.004","article-title":"Phage display: Concept, innovations, applications and future","volume":"28","author":"Pande","year":"2010","journal-title":"Biotechnol. Adv."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"6789","DOI":"10.1016\/j.vaccine.2010.07.047","article-title":"Dual expression system for assembling phage lambda display particle (LDP) vaccine to porcine Circovirus 2 (PCV2)","volume":"28","author":"Hayes","year":"2010","journal-title":"Vaccine"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"5179","DOI":"10.3390\/ijms13045179","article-title":"Filamentous Bacteriophage Fd as an Antigen Delivery System in Vaccination","volume":"13","author":"Prisco","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1016\/j.vaccine.2009.12.059","article-title":"Engineering filamentous phage carriers to improve focusing of antibody responses against peptides","volume":"28","author":"Henry","year":"2010","journal-title":"Vaccine"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/S0965-1748(02)00095-4","article-title":"Plasmodium-mosquito interactions, phage display libraries and transgenic mosquitoes impaired for malaria transmission","volume":"32","author":"Ghosh","year":"2002","journal-title":"Insect Biochem. Mol. Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"9","DOI":"10.15171\/ijb.1017","article-title":"Triple Tandem Mimotope Peptide of Epidermal Growth Factor ReceptorDisplaying on the Surface of M13 Phage Induces Anti-Tumor Response in MiceTumor Model","volume":"12","author":"Javanmardi","year":"2014","journal-title":"Iran. J. Biotechnol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1006\/viro.2000.0185","article-title":"Immunisation with Phage Displaying Peptides Representing Single Epitopes of the Glycoprotein G Can Give Rise to Partial Protective Immunity to HSV-2","volume":"269","author":"Grabowska","year":"2000","journal-title":"J. Virol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.vaccine.2011.12.070","article-title":"Peptide vaccination is superior to genetic vaccination using a recombineered bacteriophage \u03bb subunit vaccine","volume":"30","author":"Thomas","year":"2012","journal-title":"Vaccine"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.drudis.2013.09.001","article-title":"Phage display as a technology delivering on the promise of peptide drug discovery","volume":"18","author":"Alizadeh","year":"2013","journal-title":"Drug Discov. Today"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jviromet.2009.11.008","article-title":"Evaluation of humoral and cellular immune responses against HSV-1 using genetic immunization by filamentous phage particles: A comparative approach to conventional DNA vaccine","volume":"163","author":"Hashemi","year":"2010","journal-title":"J. Virol. Methods"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1021\/bc300130z","article-title":"M13 Bacteriophage Display Framework That Allows Sortase-Mediated Modification of Surface-Accessible Phage Proteins","volume":"23","author":"Hess","year":"2012","journal-title":"Bioconjug. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1128\/AAC.49.7.2874-2878.2005","article-title":"Human Volunteers Receiving Escherichia coli Phage T4 Orally: A Safety Test of Phage Therapy","volume":"49","author":"Bruttin","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"5802","DOI":"10.1016\/j.vaccine.2011.03.051","article-title":"Inhibition of tumor angiogenesis in lung cancer by T4 phage surface displaying mVEGFR2 vaccine","volume":"29","author":"Ren","year":"2011","journal-title":"Vaccine"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"12551","DOI":"10.1128\/JVI.02043-14","article-title":"Immunogenicity Studies of Proteins Forming the T4 Phage Head Surface","volume":"88","author":"Dabrowska","year":"2014","journal-title":"J. Virol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e01926-18","DOI":"10.1128\/mBio.01926-18","article-title":"A Bacteriophage T4 Nanoparticle-Based Dual Vaccine against Anthrax and Plague","volume":"9","author":"Tao","year":"2018","journal-title":"mBio"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Hashemi, H., Pouyanfard, S., Bandehpour, M., Noroozbabaei, Z., Kazemi, B., Saelens, X., and Mokhtari-Azad, T. (2012). Immunization with M2e-Displaying T7 Bacteriophage Nanoparticles Protects against Influenza A Virus Challenge. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0045765"},{"key":"ref_44","first-page":"714","article-title":"Advances in the T7 phage display system (Review)","volume":"17","author":"Deng","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.vetmic.2017.04.023","article-title":"Immunogenicity of T7 bacteriophage nanoparticles displaying G-H loop of foot-and-mouth disease virus (FMDV)","volume":"205","author":"Xu","year":"2017","journal-title":"Veter. Microbiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1479-0556-8-3","article-title":"Recombinant \u03bb-phage nanobioparticles for tumor therapy in mice models","volume":"8","author":"Ghaemi","year":"2010","journal-title":"Genet. Vaccines Ther."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e00407","DOI":"10.1016\/j.heliyon.2017.e00407","article-title":"Lambda phage-based vaccine induces antitumor immunity in hepatocellular carcinoma","volume":"3","author":"Iwagami","year":"2017","journal-title":"Heliyon"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.virol.2005.10.037","article-title":"In vitro binding of anthrax protective antigen on bacteriophage T4 capsid surface through Hoc\u2013capsid interactions: A strategy for efficient display of large full-length proteins","volume":"345","author":"Shivachandra","year":"2006","journal-title":"J. Virol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jviromet.2006.09.017","article-title":"Bacteriophage T4 nanoparticle capsid surface SOC and HOC bipartite display with enhanced classical swine fever virus immunogenicity: A powerful immunological approach","volume":"139","author":"Wu","year":"2007","journal-title":"J. Virol. Methods"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Pavoni, E., Vaccaro, P., D\u2019Alessio, V., De Santis, R., and Minenkova, O. (2013). Simultaneous display of two large proteins on the head and tail of bacteriophage lambda. BMC Biotechnol., 13.","DOI":"10.1186\/1472-6750-13-79"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Hess, K.L., and Jewell, C.M. (2019). Phage display as a tool for vaccine and immunotherapy development. Bioeng. Transl. Med., 5.","DOI":"10.1002\/btm2.10142"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12929-016-0285-9","article-title":"Phage display as a promising approach for vaccine development","volume":"23","author":"Bakhshinejad","year":"2016","journal-title":"J. Biomed. Sci."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Goracci, M., Pignochino, Y., and Marchio\u2019, S. (2020). Phage Display-Based Nanotechnology Applications in Cancer Immunotherapy. Molecular, 25.","DOI":"10.3390\/molecules25040843"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10330-006-0474-1","article-title":"Immunotherapy of EGFR-positive tumor based on recombinant EGFR phage vaccine","volume":"5","author":"Liu","year":"2006","journal-title":"Chinese-German J. Clin. Oncol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/aps.2009.44","article-title":"Antitumor activity of endogenous mFlt4 displayed on a T4 phage nanoparticle surface","volume":"30","author":"Ren","year":"2009","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_56","first-page":"3991","article-title":"Anticancer activity of bacteriophage T4 and its mutant HAP1 in mouse experimental tumour models","volume":"24","author":"Dabrowska","year":"2005","journal-title":"Anticancer. Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.4049\/jimmunol.0800224","article-title":"Tumor-Specific Bacteriophages Induce Tumor Destruction through Activation of Tumor-Associated Macrophages","volume":"182","author":"Eriksson","year":"2009","journal-title":"J. Immunol."},{"key":"ref_58","first-page":"455","article-title":"Displaying of GnRH Peptides on Bacteriophage T7 and Its Immunogenicity in Mice Model","volume":"11","author":"Xu","year":"2017","journal-title":"World Acad. Sci. Eng. Technol. Int. J. Bioeng. Life Sci."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1006\/viro.1997.8632","article-title":"Protective Immune Responses Induced by the Immunization of Mice with a Recombinant Bacteriophage Displaying an Epitope of the Human Respiratory Syncytial Virus","volume":"234","author":"Bastien","year":"1997","journal-title":"J. Virol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"4860","DOI":"10.1016\/j.vaccine.2005.05.024","article-title":"The potential of phage display virions expressing malignant tumor specific antigen MAGE-A1 epitope in murine model","volume":"23","author":"Fang","year":"2005","journal-title":"Vaccine"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1016\/S0264-410X(00)00561-2","article-title":"Induction of hepatitis B virus-specific cytotoxic T lymphocytes response in vivo by filamentous phage display vaccine","volume":"19","author":"Wan","year":"2001","journal-title":"Vaccine"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.4049\/jimmunol.180.6.3719","article-title":"The use of filamentous bacteriophage fd to deliver MAGE-A10 or MAGE-A3 HLA-A2-restricted peptides and to induce strong antitumor CTL responses","volume":"180","author":"Sartorius","year":"2008","journal-title":"J. Immunol."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Tao, P., Mahalingam, M., Kirtley, M.L., Van Lier, C.J., Sha, J., Yeager, L.A., Chopra, A.K., and Rao, V.B. (2013). Mutated and Bacteriophage T4 Nanoparticle Arrayed F1-V Immunogens from Yersinia pestis as Next Generation Plague Vaccines. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003495"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.clim.2008.10.012","article-title":"Immunodiagnosis of human neurocysticercosis using a synthetic peptide selected by phage-display","volume":"131","author":"Hell","year":"2009","journal-title":"Clin. Immunol."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Becker, M., Felsberger, A., Frenzel, A., Shattuck, W.M.C., Dyer, M., K\u00fcgler, J., Zantow, J., Mather, T.N., and Hust, M. (2015). Application of M13 phage display for identifying immunogenic proteins from tick (Ixodes scapularis) saliva. BMC Biotechnol., 15.","DOI":"10.1186\/s12896-015-0167-3"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.4314\/tjpr.v14i7.5","article-title":"Identification of Immunotopes against Mycobacterium leprae as Immune Targets Using PhDTm- 12mer Phage Display Peptide Library","volume":"14","author":"Ferdosian","year":"2015","journal-title":"Trop. J. Pharm. Res."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Meyer, T., Schirrmann, T., Frenzel, A., Miethe, S., Stratmann-Selke, J., Gerlach, G.F., Strutzberg-Minder, K., D\u00fcbel, S., and Hust, M. (2012). Identification of immunogenic proteins and generation of antibodies against Salmonella Typhimurium using phage display. BMC Biotechnol., 12.","DOI":"10.1186\/1472-6750-12-29"},{"key":"ref_68","first-page":"49","article-title":"Identification and Characterization of Novel Binding Epitope of Tetanus Toxoid by Phage Display Peptide Library","volume":"9","author":"Biradhar","year":"2015","journal-title":"Curr. Trends Biotechnol. Pharm."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.toxicon.2016.11.247","article-title":"Identification of the immunogenic epitopes of the whole venom component of the Hemiscorpius lepturus scorpion using the phage display peptide library","volume":"124","author":"Jahdasani","year":"2016","journal-title":"Toxicon"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1517\/14712590902870386","article-title":"Mimotope vaccination\u2014From allergy to cancer","volume":"9","author":"Knittelfelder","year":"2009","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.imlet.2007.07.008","article-title":"Mimotope vaccines: Epitope mimics induce anti-cancer antibodies","volume":"113","author":"Riemer","year":"2007","journal-title":"Immunol. Lett."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"6511","DOI":"10.1128\/IAI.69.10.6511-6514.2001","article-title":"Epitope Mapping of Neutralizing Botulinum Neurotoxin A Antibodies by Phage Display","volume":"69","author":"Mullaney","year":"2001","journal-title":"Infect. Immun."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2174\/1386207033329779","article-title":"Potential of peptides selected from random phage-displayed libraries to mimic conformational epitopes: A study on scorpion toxin Cn2 and the neutralizing monoclonal antibody BCF2","volume":"6","author":"Gazarian","year":"2003","journal-title":"Comb. Chem. High. Throughput Screen."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0076-6879(96)67008-6","article-title":"[6] Immunization with phage-displayed mimotopes","volume":"Volume 267","author":"Monaci","year":"1996","journal-title":"Methods in Enzymology"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"4707","DOI":"10.1128\/IAI.72.8.4707-4715.2004","article-title":"Novel Phage Display-Based Subtractive Screening To Identify Vaccine Candidates of Brugia malayi","volume":"72","author":"Gnanasekar","year":"2004","journal-title":"Infect. Immun."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.molbiopara.2011.09.001","article-title":"Identification of phage display peptides with affinity for the tegument of Schistosoma japonicum schistosomula","volume":"180","author":"Liu","year":"2011","journal-title":"Mol. Biochem. Parasitol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.peptides.2011.10.003","article-title":"Synthetic peptide-targeted selection of phage display mimotopes highlights immunogenic features of \u03b1-helical vs non-helical epitopes of Taenia solium paramyosin: Implications for parasite- and host-protective roles of the protein","volume":"34","author":"Gazarian","year":"2012","journal-title":"Peptides"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"26","DOI":"10.11599\/germs.2013.1034","article-title":"DNA vaccines: Roles against diseases","volume":"3","author":"Khan","year":"2013","journal-title":"Germs"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1016\/j.vaccine.2003.10.047","article-title":"Genetic immunisation against hepatitis B using whole bacteriophage \u03bb particles","volume":"22","author":"March","year":"2004","journal-title":"Vaccine"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"453","DOI":"10.4161\/hv.4.6.6200","article-title":"Molecular and cellular mechanisms of DNA vaccines","volume":"4","author":"Coban","year":"2008","journal-title":"Hum. Vaccines"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jbiotec.2012.08.012","article-title":"The future of human DNA vaccines","volume":"162","author":"Li","year":"2012","journal-title":"J. Biotechnol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0140-6736(20)31604-4","article-title":"Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: A preliminary report of a phase 1\/2, single-blind, randomised controlled trial","volume":"396","author":"Folegatti","year":"2020","journal-title":"Lancet"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2174\/1389201013378671","article-title":"Phage displayed biomolecules as preventive and therapeutic agents","volume":"2","author":"Manoutcharian","year":"2001","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.vaccine.2018.11.050","article-title":"A cost analysis of producing vaccines in developing countries","volume":"37","author":"Munira","year":"2019","journal-title":"Vaccine"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Torres-Acosta, M., Gonz\u00e1lez-Mora, A., Ruiz-Ruiz, F., Rito-Palomares, M., Benavides, J., and Torres-Acosta, M. (2020). Economic evaluation of M13 bacteriophage production at large-Scale for therapeutic applications using aqueous Two-Phase systems. J. Chem. Technol. Biotechnol.","DOI":"10.1002\/jctb.6526"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1007\/s00216-005-3289-y","article-title":"Thermostability of landscape phage probes","volume":"382","author":"Brigati","year":"2005","journal-title":"Anal. Bioanal. Chem."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.addr.2019.01.003","article-title":"Bacteriophage interactions with mammalian tissue: Therapeutic applications","volume":"145","author":"Huh","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4161\/bact.1.1.14942","article-title":"Phages in nature","volume":"1","author":"Clokie","year":"2011","journal-title":"Bacteriophage"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"7724","DOI":"10.1158\/0008-5472.CAN-05-4441","article-title":"Selection of Tumor-binding Ligands in Cancer Patients with Phage Display Libraries","volume":"66","author":"Krag","year":"2006","journal-title":"Cancer Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s12223-011-0039-8","article-title":"The influence of external factors on bacteriophages\u2014Review","volume":"56","year":"2011","journal-title":"Folia Microbiol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1517\/17425247.2014.927437","article-title":"Bacteriophages as vehicles for gene delivery into mammalian cells: Prospects and problems","volume":"11","author":"Bakhshinejad","year":"2014","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4161\/bact.1.2.14590","article-title":"Pros and cons of phage therapy","volume":"1","author":"Abedon","year":"2011","journal-title":"Bacteriophage"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1016\/j.vaccine.2006.01.001","article-title":"Filamentous phage as an immunogenic carrier to elicit focused antibody responses against a synthetic peptide","volume":"24","author":"Zwick","year":"2006","journal-title":"Vaccine"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Van Belleghem, J.D., D\u0105browska, K., Vaneechoutte, M., Barr, J.J., and Bollyky, P.L. (2018). Interactions between Bacteriophage, Bacteria, and the Mammalian Immune System. Viruses, 11.","DOI":"10.3390\/v11010010"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.bbrc.2010.09.094","article-title":"Immunological basis of M13 phage vaccine: Regulation under MyD88 and TLR9 signaling","volume":"402","author":"Hashiguchi","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0166-3542(96)00951-5","article-title":"Anti-vaccinia virus effect of M13 bacteriophage DNA","volume":"31","author":"Mori","year":"1996","journal-title":"Antivir. Res."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"6482","DOI":"10.1128\/JVI.75.14.6482-6491.2001","article-title":"CpG Oligodeoxynucleotides with Hepatitis B Surface Antigen (HBsAg) for Vaccination in HBsAg-Transgenic Mice","volume":"75","author":"Payette","year":"2001","journal-title":"J. Virol."},{"key":"ref_98","first-page":"4","article-title":"CpG Motif in Phage Genome DNA Enhanced the Efficacy of Phage Therapy by Immunostimulation","volume":"4","author":"Golkar","year":"2012","journal-title":"Cureus"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1172\/JCI118894","article-title":"Activation of human B cells by phosphorothioate oligodeoxynucleotides","volume":"98","author":"Liang","year":"1996","journal-title":"J. Clin. Investig."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1158\/1078-0432.361.11.1","article-title":"Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances tumor response to fractionated radiotherapy","volume":"11","author":"Ariga","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Kim, A., Shin, T.-H., Shin, S.-M., Pham, C.D., Choi, D.-K., Kwon, M.-H., and Kim, Y.-S. (2012). Cellular Internalization Mechanism and Intracellular Trafficking of Filamentous M13 Phages Displaying a Cell-Penetrating Transbody and TAT Peptide. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0051813"},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Jo\u0144czyk-Matysiak, E., Weber-D\u0105browska, B., Owczarek, B., Mi\u0119dzybrodzki, R., \u0141usiak-Szelachowska, M., \u0141odej, N., and G\u00f3rski, A. (2017). Phage-Phagocyte Interactions and Their Implications for Phage Application as Therapeutics. Viruses, 9.","DOI":"10.3390\/v9060150"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"27206","DOI":"10.1038\/srep27206","article-title":"A Lipid Based Antigen Delivery System Efficiently Facilitates MHC Class-I Antigen Presentation in Dendritic Cells to Stimulate CD8+ T Cells","volume":"6","author":"Maji","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1002\/eji.201141526","article-title":"Vaccination with filamentous bacteriophages targeting DEC-205 induces DC maturation and potent anti-tumor T-cell responses in the absence of adjuvants","volume":"41","author":"Sartorius","year":"2011","journal-title":"Eur. J. Immunol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1365-2567.2006.02325.x","article-title":"Enhancement of DNA vaccine potency through linkage of antigen to filamentous bacteriophage coat protein III domain I","volume":"117","author":"Cuesta","year":"2006","journal-title":"Immunology"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1017\/S003118200800471X","article-title":"Induction of immunity in sheep toFasciola hepaticawith mimotopes of cathepsin L selected from a phage display library","volume":"135","author":"Mancera","year":"2008","journal-title":"Parasitology"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.ejpb.2008.06.005","article-title":"Non-specific translocation of peptide-displaying bacteriophage particles across the gastrointestinal barrier","volume":"70","author":"Mahmoudpour","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jviromet.2003.11.012","article-title":"Identification of peptide sequences that induce the transport of phage across the gastrointestinal mucosal barrier","volume":"116","author":"Duerr","year":"2004","journal-title":"J. Virol. Methods"},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Sartorius, R., D\u2019Apice, L., Prisco, A., and De Berardinis, P. (2019). Arming Filamentous Bacteriophage, a Nature-Made Nanoparticle, for New Vaccine and Immunotherapeutic Strategies. Pharmaceutics, 11.","DOI":"10.3390\/pharmaceutics11090437"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/S0264-410X(97)00072-8","article-title":"Immunogenicity of filamentous phage displaying peptide mimotopes after oral administration","volume":"15","author":"Delmastro","year":"1997","journal-title":"Vaccine"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.vaccine.2007.12.053","article-title":"Orally delivered foot-and-mouth disease virus capsid protomer vaccine displayed on T4 bacteriophage surface: 100% protection from potency challenge in mice","volume":"26","author":"Ren","year":"2008","journal-title":"Vaccine"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/8\/3\/504\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:06:46Z","timestamp":1760177206000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/8\/3\/504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,4]]},"references-count":111,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,9]]}},"alternative-id":["vaccines8030504"],"URL":"https:\/\/doi.org\/10.3390\/vaccines8030504","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,4]]}}}